Windsor Capital Management’s Elevance Health ELV Stock Holding History

Windsor Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-445	Closed	-$218K	–	117
2022 Q1	$218K	Sell	445 -57	-11%	-$26.1K	0.07%	115
2021 Q4	$233K	Sell	502 -133	-21%	-$56K	0.07%	108
2021 Q3	$236K	Buy	635 +1	+0.2%	+$380	0.08%	107
2021 Q2	$242K	Sell	634 -24	-4%	-$9.17K	0.08%	107
2021 Q1	$236K	Buy	658 +1	+0.2%	+$322	0.08%	107
2020 Q4	$211K	Buy	+657	New	+$202K	0.08%	114
2015 Q4	–	Sell	-890	Closed	-$124K	–	180
2015 Q3	$124K	Buy	+890	New	+$134K	0.07%	119
2014 Q1	–	Sell	-880	Closed	-$81K	–	130
2013 Q4	$81K	Buy	880 +2	+0.2%	+$178	0.05%	134
2013 Q3	$73K	Buy	878 +2	+0.2%	+$171	0.04%	142
2013 Q2	$72K	Buy	+876	New	+$65.6K	0.04%	138

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Windsor Capital Management's ELV Position: Q2 2022 in Review

Windsor Capital Management sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 445 shares — an estimated $218K sold.

Windsor Capital Management first reported a position in ELV in Q2 2013 and held it in 10 quarters. The position peaked at $242K in Q2 2021. 1,443 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

Windsor Capital Management reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
Windsor Capital Management sold 445 Elevance Health shares in Q2 2022, an estimated $218K.
Windsor Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 10 quarters.
Windsor Capital Management's Elevance Health position peaked at $242K in Q2 2021.
1,443 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Windsor Capital Management's 13F filing for Q2 2022, filed 14 Jul 2022.